Green Thumb Industries Inc. (OTCMKTS:GTBIF) Given Consensus Rating of “Strong Buy” by Analysts

Shares of Green Thumb Industries Inc. (OTCMKTS:GTBIF) have been given an average rating of “Strong Buy” by the six brokerages that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a buy recommendation and three have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $16.50.

A number of equities research analysts have recently weighed in on the company. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th. Ventum Cap Mkts raised Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th. Finally, Roth Capital raised Green Thumb Industries to a “strong-buy” rating in a research note on Sunday, November 10th.

Green Thumb Industries Stock Down 2.1 %

Shares of GTBIF stock opened at $9.41 on Tuesday. The business has a 50-day moving average price of $10.20 and a two-hundred day moving average price of $11.00. Green Thumb Industries has a 12-month low of $7.50 and a 12-month high of $16.33. The firm has a market cap of $1.99 billion, a P/E ratio of 34.85 and a beta of 1.40.

Green Thumb Industries (OTCMKTS:GTBIF) last released its earnings results on Thursday, November 7th. The company reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The company had revenue of $286.87 million during the quarter, compared to the consensus estimate of $283.96 million. As a group, research analysts expect that Green Thumb Industries will post 0.32 EPS for the current fiscal year.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.